Cargando…
miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours
Deregulated proliferation is a hallmark of cancer cells. Here, we show that microRNA-10b* is a master regulator of breast cancer cell proliferation and is downregulated in tumoural samples versus matched peritumoural counterparts. Two canonical CpG islands (5 kb) upstream from the precursor sequence...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494877/ https://www.ncbi.nlm.nih.gov/pubmed/23125021 http://dx.doi.org/10.1002/emmm.201201483 |
_version_ | 1782249448890433536 |
---|---|
author | Biagioni, Francesca Bossel Ben-Moshe, Noa Fontemaggi, Giulia Canu, Valeria Mori, Federica Antoniani, Barbara Di Benedetto, Anna Santoro, Raffaela Germoni, Sabrina De Angelis, Fernanda Cambria, Anna Avraham, Roi Grasso, Giuseppe Strano, Sabrina Muti, Paola Mottolese, Marcella Yarden, Yosef Domany, Eytan Blandino, Giovanni |
author_facet | Biagioni, Francesca Bossel Ben-Moshe, Noa Fontemaggi, Giulia Canu, Valeria Mori, Federica Antoniani, Barbara Di Benedetto, Anna Santoro, Raffaela Germoni, Sabrina De Angelis, Fernanda Cambria, Anna Avraham, Roi Grasso, Giuseppe Strano, Sabrina Muti, Paola Mottolese, Marcella Yarden, Yosef Domany, Eytan Blandino, Giovanni |
author_sort | Biagioni, Francesca |
collection | PubMed |
description | Deregulated proliferation is a hallmark of cancer cells. Here, we show that microRNA-10b* is a master regulator of breast cancer cell proliferation and is downregulated in tumoural samples versus matched peritumoural counterparts. Two canonical CpG islands (5 kb) upstream from the precursor sequence are hypermethylated in the analysed breast cancer tissues. Ectopic delivery of synthetic microRNA-10b* in breast cancer cell lines or into xenograft mouse breast tumours inhibits cell proliferation and impairs tumour growth in vivo, respectively. We identified and validated in vitro and in vivo three novel target mRNAs of miR-10b* (BUB1, PLK1 and CCNA2), which play a remarkable role in cell cycle regulation and whose high expression in breast cancer patients is associated with reduced disease-free survival, relapse-free survival and metastasis-free survival when compared to patients with low expression. This also suggests that restoration of microRNA-10b* expression might have therapeutic promise. |
format | Online Article Text |
id | pubmed-3494877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | WILEY-VCH Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-34948772012-11-13 miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours Biagioni, Francesca Bossel Ben-Moshe, Noa Fontemaggi, Giulia Canu, Valeria Mori, Federica Antoniani, Barbara Di Benedetto, Anna Santoro, Raffaela Germoni, Sabrina De Angelis, Fernanda Cambria, Anna Avraham, Roi Grasso, Giuseppe Strano, Sabrina Muti, Paola Mottolese, Marcella Yarden, Yosef Domany, Eytan Blandino, Giovanni EMBO Mol Med Research Articles Deregulated proliferation is a hallmark of cancer cells. Here, we show that microRNA-10b* is a master regulator of breast cancer cell proliferation and is downregulated in tumoural samples versus matched peritumoural counterparts. Two canonical CpG islands (5 kb) upstream from the precursor sequence are hypermethylated in the analysed breast cancer tissues. Ectopic delivery of synthetic microRNA-10b* in breast cancer cell lines or into xenograft mouse breast tumours inhibits cell proliferation and impairs tumour growth in vivo, respectively. We identified and validated in vitro and in vivo three novel target mRNAs of miR-10b* (BUB1, PLK1 and CCNA2), which play a remarkable role in cell cycle regulation and whose high expression in breast cancer patients is associated with reduced disease-free survival, relapse-free survival and metastasis-free survival when compared to patients with low expression. This also suggests that restoration of microRNA-10b* expression might have therapeutic promise. WILEY-VCH Verlag 2012-11 2012-11-02 /pmc/articles/PMC3494877/ /pubmed/23125021 http://dx.doi.org/10.1002/emmm.201201483 Text en Copyright © 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Research Articles Biagioni, Francesca Bossel Ben-Moshe, Noa Fontemaggi, Giulia Canu, Valeria Mori, Federica Antoniani, Barbara Di Benedetto, Anna Santoro, Raffaela Germoni, Sabrina De Angelis, Fernanda Cambria, Anna Avraham, Roi Grasso, Giuseppe Strano, Sabrina Muti, Paola Mottolese, Marcella Yarden, Yosef Domany, Eytan Blandino, Giovanni miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours |
title | miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours |
title_full | miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours |
title_fullStr | miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours |
title_full_unstemmed | miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours |
title_short | miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours |
title_sort | mir-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494877/ https://www.ncbi.nlm.nih.gov/pubmed/23125021 http://dx.doi.org/10.1002/emmm.201201483 |
work_keys_str_mv | AT biagionifrancesca mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT bosselbenmoshenoa mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT fontemaggigiulia mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT canuvaleria mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT morifederica mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT antonianibarbara mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT dibenedettoanna mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT santororaffaela mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT germonisabrina mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT deangelisfernanda mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT cambriaanna mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT avrahamroi mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT grassogiuseppe mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT stranosabrina mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT mutipaola mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT mottolesemarcella mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT yardenyosef mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT domanyeytan mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours AT blandinogiovanni mir10bamasterinhibitorofthecellcycleisdownregulatedinhumanbreasttumours |